Evans David Thomas 4

Accession 0001666071-20-000242

CIK 0001666071other

View on SEC.gov Company Profile

Filed

Aug 12, 8:00 PM ET

Accepted

Aug 13, 7:15 PM ET

Size

36.7 KB

Accession

0001666071-20-000242

Insider Transaction Report

Form 4

Period: 2020-08-11

Cardlytics, Inc.CDLX

Evans David Thomas

Chief Financial Officer

Transactions

Award
Restricted Stock Units
2020-08-11+208→ 208 total
→ Common Stock (208 underlying)
Exercise/Conversion
Restricted Stock Units
2020-08-11−208→ 0 total
→ Common Stock (208 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2020-08-11−741→ 5,509 total
Exercise: $20.00Exp: 2026-08-02→ Common Stock (741 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2020-08-11−700→ 11,019 total
Exercise: $30.44Exp: 2027-07-07→ Common Stock (700 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2020-08-11−700→ 7,894 total
Exercise: $20.00Exp: 2026-12-06→ Common Stock (700 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2020-08-12−5,509→ 0 total
Exercise: $20.00Exp: 2026-08-02→ Common Stock (5,509 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2020-08-12−4,769→ 6,250 total
Exercise: $30.44Exp: 2027-07-07→ Common Stock (4,769 underlying)
Exercise/Conversion
Common Stock
2020-08-11+208→ 12,987 total
Exercise/Conversion
Common Stock
2020-08-11$20.00/sh+741$14,820→ 13,728 total
Exercise/Conversion
Common Stock
2020-08-11$30.44/sh+700$21,308→ 14,428 total
Exercise/Conversion
Common Stock
2020-08-11$20.00/sh+700$14,000→ 15,128 total
Sale
Common Stock
2020-08-11$75.55/sh−13,019$983,585→ 2,109 total
Sale
Common Stock
2020-08-11$76.05/sh−401$30,496→ 1,708 total
Exercise/Conversion
Common Stock
2020-08-12$20.00/sh+5,509$110,180→ 7,217 total
Exercise/Conversion
Common Stock
2020-08-12$30.44/sh+4,769$145,168→ 11,986 total
Exercise/Conversion
Common Stock
2020-08-12$20.00/sh+4,769$95,380→ 16,755 total
Sale
Common Stock
2020-08-12$77.14/sh−15,047$1,160,726→ 1,708 total
Sale
Common Stock
2020-08-13$79.62/sh−86$6,847→ 1,622 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2020-08-12−4,769→ 3,125 total
Exercise: $20.00Exp: 2026-12-06→ Common Stock (4,769 underlying)

Footnotes (8)

[F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
[F2]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
[F3]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $76.01 to $76.09, inclusive.
[F4]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $76.64 to $77.58, inclusive.
[F5]Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs granted on August 11, 2020.
[F6]Fully vested.
[F7]This option becomes exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.
[F8]This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The options becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.

Documents

1 file

4
wf-form4_159736050594990.xmlPrimary
FORM 4

Issuer

Cardlytics, Inc.

CIK 0001666071

→

Entity typeother

Related Parties

filerCIK 0001730451

Filing Metadata

Form type: 4
Filed: Aug 12, 8:00 PM ET
Accepted: Aug 13, 7:15 PM ET
Size: 36.7 KB

View on SEC.gov